Darifenacin Hydrobromide is an antagonist of the mAChR M3 (M3 musarinnic acetylcholine receptor).
Chapple, C. Current Medical Research and Opinion (2007), 23(10), 2347-2358. Song P. Cancer research (2007), 67(8), 3936-44. Naruganahalli, K. S. European Journal of Pharmacology (2007), 572(2-3), 207-212.
See how others have used Darifenacin Hydrobromide (CAS 133099-07-7). Click on the entry to view the PubMed entry .
PMID: # 28994003 Olianas, MC. et al. 2018. Neurochem. Res. 43: 245-258.
PMID: # 27048752 Sugawara, Y. et al. 2016. Brain Res. 1642: 255-262.
PMID: # 27474091 Olianas, MC. et al. 2016. Br. J. Pharmacol. 173: 2910-28.
PMID: # 27167157 Wang, N.|Dong, BJ.|Quan, Y.|Chen, Q.|Chu, M.|Xu, J.|Xue, W.|Huang, YR.|Yang, R.|Gao, WQ.| et al. 2016. Stem Cell Reports. 6: 668-678.
PMID: # 21885618 J Pharmacol Exp Ther. 870-7.
PMID: # 25242372 Biochim. Biophys. Acta. 1843: 3004-17.